Page 1 of Clinical Trials for Drug HFA placebo, 66 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Suspended
Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients
Last Updated: January 23, 2012
Condition(s): Asthma
2
Completed
Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
Last Updated: April 21, 2010
Condition(s): Bronchial Asthma
3
Withdrawn
Randomized, Placebo/Active Controlled Crossover, Dose-ranging Study for Initial Evaluation of Safety and Efficacy in Asthma Patients.
Last Updated: March 10, 2010
Condition(s): Asthma
4
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Last Updated: May 11, 2012
Condition(s): Asthma
5
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Last Updated: May 11, 2012
Condition(s): Asthma
6
Completed
A Dose-ranging Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler (DPI) and an HFA MDI
Last Updated: September 1, 2011
Condition(s): Asthma
7
Suspended
Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction
Last Updated: January 23, 2012
Condition(s): Asthma; Bronchospasm
8
Completed
Chronic-Dose Safety and Efficacy Study of an Albuterol Metered Dose Inhaler (MDI) Inhaler Using a Hydrofluoroalkane (HFA) Propellant In Pediatric Asthmatics
Last Updated: April 11, 2012
Condition(s): Asthma
9
Completed
Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma
Last Updated: August 24, 2010
Condition(s): Mild to Moderate Asthma
10
Completed
A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands
Last Updated: November 28, 2008
Condition(s): Asthma
11
Terminated
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)
Last Updated: May 18, 2012
Condition(s): Asthma
12
Terminated
Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
Last Updated: May 18, 2012
Condition(s): Asthma
13
Completed
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
Last Updated: November 1, 2010
Condition(s): Seasonal Allergic Rhinitis
14
Completed
The Effect of HFA - Beclomethasone Dipropionate Qvar on Bronchial Hyperreactivity in Preschool Children
Last Updated: August 11, 2010
Condition(s): Asthma; Bronchial Hyperresponsiveness
15
Terminated
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
Last Updated: May 18, 2012
Condition(s): Asthma
16
Completed
Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)
Last Updated: September 1, 2011
Condition(s): Perennial Allergic Rhinitis
17
Completed
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
Last Updated: June 8, 2011
Condition(s): Asthma
18
Completed
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Last Updated: November 1, 2010
Condition(s): Allergic Rhinitis; Perennial Allergic Rhinitis
19
Completed
Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis
Last Updated: April 23, 2012
Condition(s): Rhinitis, Allergic, Perennial
20
Completed
Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
Last Updated: April 23, 2012
Condition(s): Seasonal Allergic Rhinitis; Hayfever

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+HFA+placebo

Page 1 of Clinical Trials for Drug HFA placebo, 66 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About